TickerFactsScreenerDevelopers

Mereo BioPharma Group plc (MREO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$48.82M2023: -$21.13M2024: -$32.83M2025: -$30.97M-$30.97M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$30.97M+5.7%
2024-$32.83M-55.4%
2023-$21.13M+56.7%
2022-$48.82M—